FACACLASSIC

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”

HHS - 850 - National Institute on Drug Abuse Special Emphasis Panel - Authorized by Law

GENERAL INFORMATION

Committee Name	National Institute on Drug Abuse Special Emphasis Panel	Agency Name	Department of Health and Human Services
Fiscal Year	2025	Committee Number	850
Original Establishment Date	10/27/1986	Committee Status	Terminated
Actual Termination Date	6/30/2025	Committee URL	http://www.drugabuse.gov/about-nida/advisory-bo...
Actual Merged Date		Presidential Appointments*	No
New Committee This FY	No	Max Number of Members*	Unlimited
Terminated This FY	Yes	Designated Fed Officer Position Title*	CHIEF, SCIENTIFIC REVIEW BRANCH
Merged This FY		Designated Federal Officer Prefix
Current Charter Date	8/7/1995	Designated Federal Officer First Name*	DHARMENDAR
Date Of Renewal Charter		Designated Federal Officer Middle Name
Projected Termination Date	6/30/2025	Designated Federal Officer Last Name*	RATHORE
Exempt From Renewal*	Yes	Designated Federal Officer Suffix	PHD
Specific Termination Authority	Secretary Directive 2025	Designated Federal Officer Phone*	(301) 402-6965
Establishment Authority*	Authorized by Law	Designated Federal Officer Fax*	(301) 443-0538
Specific Establishment Authority*	42 U.S.C. 282(b)(16)	Designated Federal Officer Email*	dharmendar.rathore@nih.gov
Effective Date Of Authority*	11/20/1985
Exempt From EO 13875 Discretionary Cmte	Not Applicable
Committee Type*	Continuing
Presidential*	No
Committee Function*	Special Emphasis Panel

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*	Terminate
Legislation to Terminate Required	Not Applicable
Legislation Status	Not Applicable
How does cmte accomplish its purpose?*	This committee is composed of recognized biomedical and/or behavioral research authorities who represent the forefront of research and technical knowledge and who provide first-level merit review of highly scientific and technical research grant applications in the fields relevant to drug abuse and addiction including, basic and clinical neuroscience, basic behavioral science, medications development, treatment, health services, epidemiology, prevention, human development, and AIDS. During this reporting period the committee reviewed 843 applications and requesting $2,353,724,769 and reviewed 6 contract proposals.
How is membership balanced?*	Operation of the Special Emphasis Panel is accomplished using a fluid membership, with members designated to serve for individual meetings rather than formally appointed for fixed terms of service. The reviewers for each meeting are selected to evaluate grant applications or contract proposals for a specific, perhaps narrow, expertise area. Participants for each meeting are assembled to most efficiently and effectively cover the number and breadth of applications or contracts requiring review. The members designated to this committee are authorities knowledgeable in the fields of biomedical, basic and clinical neuroscience, basic behavioral science, treatment, health services, epidemiology, prevention, human development, and AIDS.
How frequent & relevant are cmte mtgs?*	The committee held 51 meetings during this reporting period. The committee also conducted one workgroup meeting on March 14, 2025.
Why advice can't be obtained elsewhere?*	This committee is composed of recognized biomedical and/or behavioral research authorities who represent the forefront of research and technical knowledge and who provide first-level merit review of highly scientific and technical research grant applications and contract proposals. These evaluations and recommendations cannot be obtained from other sources because the specialized, complex nature of the applications and proposals requires a unique balance and breadth of expertise not available on the NIH staff or from other established sources.
Why close or partially close meetings?	The meetings of the committee were closed to the public for the review of grant applications. Sections 552b(c)(4) and 552b(c)(6) of the Government in the Sunshine Act permits the closing of meetings where discussion could reveal confidential trade secrets or commercial property such as patentable material and personal information, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Recommendation Remarks	2025 Secretary Directive-Elimination of Federal Advisory Committees Within the Department of Health and Human Services, Terminated 06.30.2025. EO 14217 Reducing the Scope of the Federal Bureaucracy. NIDA SEP did not produce a report this fiscal year. The Committee Decision Maker and the Designated Federal Officer are filled by the same individual based on assigned duties within the IC. Meetings: The meetings on 2/3/2025, 2/25/2025 and 3/27/2025 were cancelled due to shifting administrative priorities and a temporary ban on public communications. The meetings held on 4/11/2025, 4/28/2025, 4/30/2025, 5/2/2025, and 5/7/2025, were not published in the Federal Register. Members: Dr. Elizabeth Jacobs was inadvertently reported twice on the report for the previous fiscal year. The members of this Special Emphasis Panel (SEP) do not have standing appointments and serve on an as needed basis for meetings throughout the fiscal year. Therefore, the members list does not reflect appointment start and end dates. As often as possible, instead of appointment start and end dates, each meeting date on which the SEP member served is identified on the Members list. When necessary to protect peer review integrity, a fiscal year start and end date is used as the alternative to appointment start and end dates for some SEP members. As a result, the Members list, including the number of chairs, may not align or directly match to specific meeting dates. Meeting rosters, including members’ affiliations and zip codes are available online at https://public.era.nih.gov/pubroster/.

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*	No	Action Reorganize Priorities*	No
Outcome Trust In Government	No	Action Reallocate Resources	No
Outcome Major Policy Changes	No	Action Issued New Regulations	No
Outcome Advance In Scientific Research	Yes	Action Proposed Legislation	No
Outcome Effective Grant Making	Yes	Action Approved Grants Or Other Payments	Yes
Outcome Improved Service Delivery	No	Action Other	No
Outcome Increased Customer Satisfaction	No	Action Comment	An action of approved or recommended for grants receiving initial peer review by this committee does not infer that the grant will be or has been funded. Research grant applications submitted to NIH must go through a two-step review process that includes the initial peer review for scientific and technical merit and a second step of review and approval by a National Advisory Council for program relevance. In addition, prior to an award or funding being made, NIH staff must conduct an administrative review for a number of other considerations. These include alignment with NIH's funding principles, review of the project budget, assessment of the applicant's management systems, determination of applicant eligibility, and compliance with public policy requirements. After all these steps have been completed, NIH officials make funding decisions on individual grant applications.
Outcome Implement Laws/Reg Requirements	No	Grants Review*	Yes
Outcome Other	No	Number Of Grants Reviewed	843
Outcome Comment	NA	Number Of Grants Recommended	843
Cost Savings*	Unable to Determine	Dollar Value Of Grants Recommended	$2,353,724,769.00
Cost Savings Comment	NIH supported basic and clinical research accomplishments often take many years to unfold into new diagnostic tests and new ways to treat and prevent diseases. Also, there are no comparable alternative mechanisms to determine cost savings accrued using the current committee structure.	Grants Review Comment	The committees do not make approval/disapproval recommendations; instead they rate the applications on a scale ranging from 100-500.
Number Of Recommendations*	15,255	Access Contact Designated Fed. Officer*	Yes
Number Of Recommendations Comment	Grant Review	Access Agency Website	Yes
% of Recs Fully Implemented*	0.00%	Access Committee Website	Yes
% of Recs Fully Implemented Comment	Information on the research funded by NIH is available through the RePORT (Research Portfolio Online Reporting Tool) website. RePORT provides access to reports, data, and analyses of NIH research activities that advance the mission of the NIH, including information on NIH expenditures, strategic plans, reports on NIH funding, and reports on the organization and people involved in NIH research and research training. The RePORT website is located at http://report.nih.gov.	Access GSA FACA Website	Yes
% of Recs Partially Implemented*	0.00%	Access Publications	No
% of Recs Partially Implemented Comment	Information on the research funded by NIH is available through the RePORT (Research Portfolio Online Reporting Tool) website. RePORT provides access to reports, data, and analyses of NIH research activities that advance the mission of the NIH, including information on NIH expenditures, strategic plans, reports on NIH funding, and reports on the organization and people involved in NIH research and research training. The RePORT website is located at http://report.nih.gov.	Access Other	No
Agency Feedback*	Yes	Access Comment	N/A
Agency Feedback Comment*	Information resulting from closed initial peer review meetings is subject to the Freedom of Information Act. The public can view information on research projects funded by NIH on the RePORT (Research Portfolio Online Reporting Tool) website located at http://report.nih.gov.	Narrative Description*	NIH’s mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability. NIH works toward that mission by supporting the research of non-Federal scientists in universities, medical schools, hospitals, and research institutions throughout the country and abroad. The National Institute on Drug Abuse Special Emphasis Panel performs a vital function of determining the quality of scientific proposals. This evaluation serves as the basis for making funding decisions in NIDA. The Committee is meeting its mission by providing high-quality, unbiased, and timely scientific reviews in the area of drug abuse. Section 492 of the PHS Act states that The Secretary ...shall by regulation require appropriate technical and scientific peer review of (A) applications...; and (B) biomedical and behavioral research and development contracts..."

COSTS

1. Payments to Non-Federal Members*		1. Est Paymnts to Non-Fed Membrs Nxt FY*
2. Payments to Federal Members*		2. Est. Payments to Fed Members Next FY*
3. Payments to Federal Staff*		3. Estimated Payments to Federal Staff*
4. Payments to Consultants*		4. Est. Payments to Consultants Next FY*
5. Travel Reimb. For Non-Federal Membrs*		5. Est Travel Reimb Non-Fed Membr nxtFY*
6. Travel Reimb. For Federal Members*		6. Est Travel Reimb For Fed Members*
7. Travel Reimb. For Federal Staff*		7. Est. Travel Reimb to Fed Staf Nxt FY*
8. Travel Reimb. For Consultants*		8. Est Travel Reimb to Consltnts Nxt FY*
10. Other Costs		10. Est. Other Costs Next FY*
11. Total Costs	$0.00	11. Est. Total Next FY*	$0.00
Date Cost Last Modified	3/14/2025 9:20 AM	Est. Fed Staff Support Next FY*
Federal Staff Support (FTE)*		Est Cost Remarks
Cost Remarks

Interest Areas

Category Area Health Health Care Medicine Health and Health Research

Custom Links

Committee Level Reports